secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2026-03-03T23:59:59+00:00
Accession:  0001193125-26-088494
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Iterum Therapeutics requests Nasdaq hearing to appeal delisting; warns of possible wind-down
--------------------------------------------------------------------------------

- On March 3, 2026, Iterum requested a hearing before Nasdaq Hearings Panel to appeal delisting for failure to maintain $1.00 bid price.
- Hearing request automatically stays suspension scheduled for March 5, 2026, pending the hearing and any extension.
- Company also fails to meet $35M minimum market value of listed securities requirement; compliance deadline June 9, 2026.
- Evaluating strategic alternatives including possible wind-down, bankruptcy, licensing or sale of assets.
- Company states limited ability to raise capital; shareholders very unlikely to receive distribution in a wind-down.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000119312526088494/0001193125-26-088494-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000119312526088494/itrm-20260303.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-088494

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer